Miami

Florida Judge Hits Planned Parenthood With Legal Gut Punch Over 'Safer Than Tylenol' Claim

AI Assisted Icon
Published on June 03, 2026
Florida Judge Hits Planned Parenthood With Legal Gut Punch Over 'Safer Than Tylenol' ClaimSource: Google Street View

A Florida circuit judge has refused to toss a high-stakes lawsuit that accuses Planned Parenthood of falsely promoting the abortion pill as “safer than Tylenol,” keeping alive a case that could expose the organization to massive financial penalties and sweeping court orders. The May 27 ruling by First Judicial Circuit Judge J. Scott Duncan in Santa Rosa County means the case moves past the initial pleading stage and into the grind of motions and discovery.

State Filed Suit Seeking Hundreds of Millions in Penalties

Florida Attorney General James Uthmeier filed the lawsuit on Nov. 6, 2025, alleging that Planned Parenthood’s public messaging, including an X post declaring “Mifepristone is safe. Safer than Tylenol,” violates state consumer protection and racketeering laws, according to the Florida Attorney General's Office. The complaint asks the court to impose statutory penalties that it estimates at roughly $350 million and to consider far-reaching injunctive remedies, ranging from license sanctions to forced sale of real estate or even organizational dissolution. Planned Parenthood sought to have the case dismissed, while the state countered that the messaging was materially misleading to patients.

Judge Says Comparison Claim Survives Early Challenge

Judge Duncan denied Planned Parenthood’s motion to dismiss, finding that the state’s complaint goes beyond vague marketing puffery and instead targets specific comparative claims that cannot be resolved this early in the case. As reported by The Daily Wire, Duncan noted that the complaint alleges the defendants “claimed they were safer than other medications,” and that whether such statements are actionable depends on context that cannot be tested on a Rule 12-style dismissal.

What the State Says It Can Prove

The Attorney General’s office portrays Planned Parenthood’s public outreach on medication abortion as a years-long marketing campaign that intentionally downplays risks and induces consumers to obtain chemical abortions, according to the Florida Attorney General's Office. The suit leans on an EPPC insurance-database analysis and other cited studies to allege higher rates of adverse events after medication abortion, and it seeks penalties under Florida’s Deceptive and Unfair Trade Practices Act, along with remedies under the state’s RICO statute.

Planned Parenthood Pushes Back, Medical Groups Defend Drug

Planned Parenthood of Florida has blasted the lawsuit as politically motivated and a further effort to restrict abortion access in the state, the Miami Herald reported when the case was first filed. Public health authorities and leading medical organizations, meanwhile, have long maintained that mifepristone is safe when used as directed. The FDA says it approved Mifeprex (mifepristone) after a thorough review and continues to monitor its safety profile, and the American College of Obstetricians and Gynecologists has repeatedly defended the drug’s safety and effectiveness in clinical practice. The FDA and groups such as ACOG have publicly rejected claims that routine medication abortion carries unusually high risks compared with other common treatments.

Legal Stakes, Next Moves in a Closely Watched Fight

Because the state is proceeding under Florida consumer protection and racketeering statutes and seeking per-incident statutory penalties, a victory for the Attorney General could come with a heavy price tag. The complaint cites a potential $10,000 penalty for each medication abortion performed in Florida after the date the challenged language appeared online, projecting a total of roughly $350 million. Judge Duncan’s refusal to dismiss the case does not resolve who is right on the facts or the law, it simply clears the way for the state to pursue discovery and further briefing. More motions are almost certain, and if the lawsuit survives summary judgment, the parties are headed for a bruising period of fact development and likely appeals. The order was reported by The Daily Wire.

Providers, advocates, and policy makers across the country are watching closely, since the Florida case plugs directly into national battles over access to medication abortion and how providers describe medical risk. For now, the state’s challenge remains very much alive in Santa Rosa County, with proceedings unfolding at the Santa Rosa County Courthouse, 4025 Avalon Blvd., Milton, FL 32583.